Anti-CIDAMP antibodies

Anti-CIDAMP antibodies are antibodies that are directed against CIDAMPs (Calreticulin-Induced Damage-Associated Molecular Patterns).

CIDAMPs are molecular patterns that arise in the context of cell damage or stress. They belong to the group of DAMPs (Damage-Associated Molecular Patterns), which are released by damaged or apoptotic cells. DAMPs activate the immune system by alerting immune cells and triggering an inflammatory reaction.

Function of anti-CIDAMP antibodies: Anti-CIDAMP antibodies are directed against these specific molecular patterns and could be autoimmunologically as well as therapeutically relevant:

• Autoimmune diseases: The organism produces such antibodies to neutralize the DAMP signals, but this can also lead to autoimmune reactions.
• Therapeutic application: In research, anti-CIDAMP antibodies could be used specifically to modulate the excessive inflammatory response in certain diseases, such as autoimmune diseases or chronic inflammation.

1. Christophers E Schröder JM (2022) Evolution of innate defense in human skin. Exp Dermatol 31:304-311.

2. Fucikova J et al. (2016).Calreticulin expression in human non-small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis. Cancer Res76:1746-1756
3. Song, Pu et al.(2024) Membranal Expression of Calreticulin Induced by Unfolded Protein Response in Melanocytes: A Mechanism Underlying Oxidative Stress-Induced Autoimmunity in Vitiligo. Journal of Investigative Dermatology 144: 1622 - 1632.e5
4. Wang Y et al. (2019) Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity. Med Sci Monit 25:1017-1023.
5. Zhang Y et al. (2014) Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes. J Invest Dermatol 134:183-191.